MEDICINOVA INC (MNOV)

Stammdaten

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Unternehmen & Branche

NameMEDICINOVA INC
TickerMNOV
CIK0001226616
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP58468P206
ISINUS58468P2065
TypCommon Stock
Marktkapitalisierung67,4 Mio. USD
Beta0,61
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K409,657-11,997,957-0.2445,603,10941,586,681
2025-09-3010-Q123,319-3,050,373-0.0647,578,38843,964,756
2025-06-3010-Q134,599-3,281,185-0.0749,823,87546,856,869
2025-03-3110-Q-2,864,120-0.0652,431,15049,930,476
2024-12-3110-K-11,049,549-0.2355,875,92652,503,551
2024-09-3010-Q-2,852,179-0.0658,119,42155,065,561
2024-06-3010-Q-2,628,200-0.0560,403,80857,405,154
2024-03-3110-Q-2,754,518-0.0662,893,91759,830,444
2023-12-3110-K1,000,000-8,571,516-0.1766,269,97762,378,424
2023-09-3010-Q1,000,000-723,107-0.0168,136,56164,669,252
2023-06-3010-Q-2,871,820-0.0668,718,64265,175,929
2023-03-3110-Q-2,917,504-0.0671,132,84567,726,252
2022-12-3110-K-14,069,083-0.2974,154,90570,242,035
2022-09-3010-Q-3,652,184-0.0778,391,77073,105,871
2022-06-3010-Q-4,028,998-0.0881,235,59676,605,729
2022-03-3110-Q-3,386,417-0.0784,175,18780,364,285
2021-12-3110-K4,037,500-10,134,252-0.2187,406,45883,677,084
2021-09-3010-Q37,500-3,579,167-0.0791,623,96086,482,340
2021-06-3010-Q4,000,000-4,284,141-0.0993,683,84889,234,314
2021-03-3110-Q4,000,000-187,79996,100,71992,371,449

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Essex Woodlands Management, Inc.1,105,94101,105,9411,448,783Neu+100,0%
VANGUARD GROUP INC705,6250705,625924,369Neu+100,0%
BlackRock, Inc.704,9700704,970923,510Neu+100,0%
CITIGROUP INC635,7150635,715832,787Neu+100,0%
DRW Securities, LLC3,80003,800820,800Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC529,5830529,583693,926Neu+100,0%
UBS Group AG225,6610225,661295,616Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC196,8000196,800257,808Neu+100,0%
STATE STREET CORP193,6980193,698253,744Neu+100,0%
JANE STREET GROUP, LLC163,0960163,096213,655Neu+100,0%
NORTHERN TRUST CORP133,1630133,163174,444Neu+100,0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC76,031076,03199,601Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC71,506071,50693,673Neu+100,0%
DIMENSIONAL FUND ADVISORS LP65,015065,01585,170Neu+100,0%
SBI Securities Co., Ltd.45,232045,23259,254Neu+100,0%
TWO SIGMA INVESTMENTS, LP39,736039,73652,054Neu+100,0%
BARCLAYS PLC39,400039,40051,614Neu+100,0%
Schonfeld Strategic Advisors LLC36,047036,04747,220Neu+100,0%
BANK OF AMERICA CORP /DE/30,003030,00339,304Neu+100,0%
CITADEL ADVISORS LLC28,712028,71237,613Neu+100,0%
GOLDMAN SACHS GROUP INC26,480026,48034,689Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP22,753022,75329,806Neu+100,0%
StoneX Group Inc.19,200019,20025,152Neu+100,0%
Focus Partners Advisor Solutions, LLC10,000010,00013,100Neu+100,0%
MORGAN STANLEY2,00002,0002,620Neu+100,0%
Tower Research Capital LLC (TRC)1,84601,8462,418Neu+100,0%
SIMPLEX TRADING, LLC1,10001,1001,441Neu+100,0%
JPMORGAN CHASE & CO5760576755Neu+100,0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO3050305400Neu+100,0%
GROUP ONE TRADING LLC3000300393Neu+100,0%
OSAIC HOLDINGS, INC.6606686Neu+100,0%
HANTZ FINANCIAL SERVICES, INC.4,30004,3006Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-09491,3667
2026-03-0431,414
2026-02-27361,5255
2026-02-23961,50144

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
Essex Woodlands Management, Inc.1,105,9411,448,78319.28
VANGUARD GROUP INC705,625924,36912.30
BlackRock, Inc.704,970923,51012.29
CITIGROUP INC635,715832,78711.08
DRW Securities, LLC3,800820,80010.92
GEODE CAPITAL MANAGEMENT, LLC529,583693,9269.23
UBS Group AG225,661295,6163.93
RENAISSANCE TECHNOLOGIES LLC196,800257,8083.43
STATE STREET CORP193,698253,7443.38
JANE STREET GROUP, LLC163,096213,6552.84
NORTHERN TRUST CORP133,163174,4442.32
BRIDGEWAY CAPITAL MANAGEMENT, LLC76,03199,6011.33
CHARLES SCHWAB INVESTMENT MANAGEMENT INC71,50693,6731.25
DIMENSIONAL FUND ADVISORS LP65,01585,1701.13
SBI Securities Co., Ltd.45,23259,2540.79
TWO SIGMA INVESTMENTS, LP39,73652,0540.69
BARCLAYS PLC39,40051,6140.69
Schonfeld Strategic Advisors LLC36,04747,2200.63
BANK OF AMERICA CORP /DE/30,00339,3040.52
CITADEL ADVISORS LLC28,71237,6130.50

Hinweis

Erweitert ×